Connecticut-based Loxo Oncology, which was founded in 2013 and went public a year later, has a cancer drug in development that recently received U.S. Food and Drug Administration "breakthrough therapy" status.
Bristol-Myers and Celgene combined will have nine products with more than $1 billion in annual sales and significant potential for growth in the core disease areas of oncology, immunology and cardiovascular disease.
The frenzy of deal-making inevitably leads to speculation about the future of WTHR-TV Channel 13—which, incredibly, has been under the ownership of the same family—the Wolfes of Columbus, Ohio—since 1975.
As part of its $4.1 deal to acquire Tribune Media Co., Nexstar Media must sell TV stations in numerous markets to avoid regulatory problems. Those sales are almost certain to involve stations in Indianapolis.